References to evidence of weight regain after stopping treatment often reinforce this perspective, although sentiment varies widely based on personal experience, cost, and access
Currently, the SURPASS-CVOT trial is evaluating the impact of dulaglutide and tirzepatide on cardiovascular events in patients with T2D (NCT04255433)
Consider incorporating relaxation techniques such as deep breathing exercises, meditation, or progressive muscle relaxation into your daily routine
Its an intriguing idea, but much of this messaging oversimplifies how GLP-1 actually works in the body
As in the group with overweight or obesity, people taking semaglutide had a lower risk of suicidal thoughts than those taking non-GLP1R agonist drugs
Given that Im a bit of a scaredy cat about medicines, I thought a microdose would make me feel better about it